AGL2043 is a potent inhibitor of PDGFR (IC50 = 0.8 μM), TEL-PDGFR, FLT3, and KIT kinases; it effectively inhibits porcine cardiac smooth muscle cell proliferation and balloon-induced vascular restenosis, making it suitable for development as an anti-restenotic and anticancer agent.